ClinicalTrials.Veeva

Menu

Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

Duke University logo

Duke University

Status

Enrolling

Conditions

Sarcoidosis

Study type

Observational

Funder types

Other

Identifiers

NCT01745237
Pro00008224
DCMRC-8224a (Other Identifier)

Details and patient eligibility

About

The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.

Full description

In patients with sarcoidosis, cardiac death is a leading cause of mortality which may represent unrecognized cardiac involvement. Cardiovascular magnetic resonance (CMR) can detect cardiac involvement including minute amounts of myocardial damage. Therefore, the objective of this study was to determine the usefulness of CMR and compare it with standard clinical evaluation for cardiac involvement. Patients with documented extracardiac sarcoidosis or clinically suspected cardiac sarcoidosis will be enrolled.

Enrollment

27,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Biopsy proven sarcoidosis
  • Suspected cardiac sarcoidosis

Exclusion criteria

  • Contraindication to MRI

Trial contacts and locations

1

Loading...

Central trial contact

Raymond J. Kim, MD; Han W Kim, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems